Strata Critical Medical (SRTA) vs Starling Oncology (STLN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Starling Oncology (STLN) has outperformed Strata Critical Medical (SRTA) over the past year, gaining 68.3% versus a loss of 9.1%. Over five years, STLN leads with a -35.4% price change compared with -54.4% for SRTA. Starling Oncology is the larger company by market cap ($655.3 million vs $414.0 million), about 1.6 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SRTA | STLN |
|---|---|---|
| Share price | $4.68 | $6.43 |
| Market cap | $414.02M | $655.32M |
| 1-day change | -1.47% | -2.28% |
| YTD return | -2.70% | +80.62% |
| 1-year return | -9.13% | +68.32% |
| 5-year return | -54.39% | -35.38% |
| EPS (TTM) | $-0.28 | $-0.28 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.50 | $7.13 |
| 52-week low | $3.95 | $2.32 |
| Distance from 52-week high | -28.00% | -9.82% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +104.27% | +39.97% |
| Average volume | 938.61K | 1.55M |
| Shares outstanding | 88.47M | 101.92M |
| Employees | 327 | 641 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Care Facilities | Medical Care Facilities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- STLN has outperformed SRTA by 77.5 percentage points over the past year.
About Strata Critical Medical
SRTA stock →Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States.
Healthcare · Medical Care Facilities · 327 employees
About Starling Oncology
STLN stock →Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other.
Healthcare · Medical Care Facilities · 641 employees
SRTA vs STLN FAQ
Which is bigger, Strata Critical Medical or Starling Oncology?
Starling Oncology (STLN) is larger, with a market capitalization of $655.32M compared with $414.02M for Strata Critical Medical (SRTA).
Which stock has performed better over the past year, SRTA or STLN?
STLN returned +68.32% over the past 12 months, compared with -9.13% for SRTA (price return, excluding dividends). Past performance does not predict future results.
Are Strata Critical Medical and Starling Oncology in the same industry?
Yes. Both are classified in the Medical Care Facilities industry within the Healthcare sector.